Tech Company Financing Transactions
Syntropic Medical Funding Round
aws Gründerfonds, Xista Science Ventures and private investors participated in a funding round for Syntropic Medical. The round closed on 4/4/2024.
Transaction Overview
Company Name
Announced On
4/4/2024
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
aws Gründerfonds (Lead Investor)
Xista Science Ventures (Lead Investor) (Florian Resch)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Undisclosed
Vienna, Undisclosed
Austria
Vienna, Undisclosed
Austria
Phone
Undisclosed
Website
Email Address
Overview
Syntropic is a pre-clinical stage medical device company developing new technologies that enhance the brain's neuroplasticity, allowing for the treatment of psychiatric disorders and the improvement of cognition. Syntropic's mission is to advance mental health care through the development of innovative technologies that target underlying causes of brain disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Caffrey
Chief Technical Officer
Jack O'Keeffe
Co-Founder
Sandra Siegert
VP - R & D
Alessandro Venturino
Browse more venture capital transactions:
Prev: 4/4/2024: SiMa.ai venture capital transaction
Next: 4/4/2024: Hello Alice venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on tech company VC transactions. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs